What We're Reading: Page 271
Industry reads hand-picked by our editors
Jul 18, 2018
-
FierceBiotech
For 2 biotech employees, coming out as trans means asking others to transition with them
-
CNN
Are 'breakthrough' drugs as safe as other FDA-approved medicines?
-
Kaiser Health News
Staggering prices slow insurers’ coverage of CAR-T cancer therapy
-
The Wall Street Journal
Biotech IPO boom comes with side effects
Jul 17, 2018
Jul 16, 2018
-
The Wall Street Journal
This Form of Ambien Now Costs Over 800% More
-
Bloomberg
Beating the Next Superbug Needs a Big Pharma Payoff
-
The Boston Globe
Biotech revolution can serve the animal kingdom
Jul 13, 2018
-
Bloomberg
Many drugmakers ignore Trump — and raise prices anyway
-
The Wall Street Journal
South Korea regulator says Samsung BioLogics violated accounting rules
-
CNBC
Alphabet Verily, ResMed to spin out a start-up to address sleep apnea
-
Financial Times
The drug pricing playbook: how pharma companies keep costs high
Jul 12, 2018
-
Reuters
With U.S. trade under a cloud, China opens to Indian pharma
-
STAT
CRISPR makes cancer cells turncoats that attack tumor, mouse study finds
-
Xconomy
EU regulators approve Akcea's inotersen. FDA decisions are next.
-
NPR
Experimental drugs boost elderly immune systems, raising hopes for anti-aging effects
Jul 11, 2018
Jul 10, 2018
-
Southern Investigative Reporting Foundation
Acadia Pharmaceuticals: This is not a pharmaceuticals company
-
The Atlantic
Anti-vaxxers are targeting a vaccine for a virus deadlier than Ebola
-
NPR
Scientists find new tricks for old drugs
-
Science
Hidden conflicts?
Previous
